Product NDC: | 60505-3583 |
Proprietary Name: | Abacavir Sulfate |
Non Proprietary Name: | Abacavir Sulfate |
Active Ingredient(s): | 300 mg/1 & nbsp; Abacavir Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-3583 |
Labeler Name: | Apotex Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201570 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121217 |
Package NDC: | 60505-3583-0 |
Package Description: | 6 BLISTER PACK in 1 CARTON (60505-3583-0) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 60505-3583-0 |
Proprietary Name | Abacavir Sulfate |
Package Description | 6 BLISTER PACK in 1 CARTON (60505-3583-0) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 60505-3583 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Abacavir Sulfate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20121217 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp |
Substance Name | ABACAVIR SULFATE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |